Neuss (ots) - In der kommenden Legislaturperiode - somit ab 2018 - soll das E-Health-Gesetz um einen zweiten ...
MSD Signs Partnership With BMJ Group
Berlin (ots/PRNewswire) -
- univadis(R) Users Gain Access to BMJ Learning Content for CME and CPD
The pharmaceutical company MSD (known as Merck Sharp & Dohme Limited in the UK and Merck & Co., Inc. in the US) and BMJ (British Medical Journal) Group today announced a partnership in medical education through which BMJ Learning will be made available to physicians through MSD's medical portal univadis(R). This unique partnership will change the face of medical education in Europe and beyond, allowing users access to most of BMJ Learning's library of 'Continuing Medical Education' (CME) and 'Continuing Professional Development' (CPD) content. The agreement between MSD and BMJ Group comprises about 350 interactive learning courses in over 20 medical therapy areas. The partnership will allow physicians to combine online CME/CPD and offline learning.
univadis(R) (http://www.univadis.com), one of the leading medical Internet services in Europe, the Middle East, Africa and Canada with more than half a million registered physicians, is a pioneer in medical education, meeting the need for high-quality accredited education for physicians, enabling them to better manage their patients and their outcomes. In addition to the educational offer, univadis(R) provides a number of tailored medical information sources based on continuous needs assessment of healthcare professionals. univadis(R) will start to cover a growing number of combined online and offline training programmes, making medical education more effective.
BMJ Learning is one of the world's largest and most trusted independent online learning and course providers for medical professionals. BMJ Group is dedicated to the expansion of BMJ Learning with new peer-reviewed and evidence-based courses launching every week.
This partnership with univadis(R) will play a crucial role in opening the gateway for physicians into BMJ Learning. "BMJ Learning is already used by 82,000 doctors in the UK and this partnership will enable doctors in many different countries to benefit from BMJ Group's expertise in medical education," says Michael Chamberlain, Chairman of BMJ Group.
Dr. Ottfried Zierenberg, Regional Medical Director Europe, Middle East, Africa & Canada of MSD, commented "We chose to work with the BMJ Group because they are one of the most respected medical courses providers, making them a perfect partner for us. This collaboration intends to ultimately increase the health outcome for patients. Additionally, it strengthens the position of univadis(R) as a trusted, professional and comprehensive news, information and educational resource for the medical community".
BMJ Learning online courses will be available on univadis(R) in English language in English speaking countries, i.e. UK and Ireland, as well as in Scandinavian countries beginning June 2008. Other countries, like Germany, will follow within 2008 once the translation process is finished.
Merck Sharp & Dohme Limited (MSD) is the UK subsidiary of Merck & Co., Inc., of Whitehouse Station, New Jersey, USA, a leading research-based pharmaceutical company that discovers, develops, manufactures and markets a wide range of innovative pharmaceutical products to improve human health.
About BMJ Group
BMJ Group is one of the world's leading providers of trusted medical information for healthcare professionals and patients. BMJ Group provides through BMJ Learning, continuing professional development online modules and exam revision materials, as well as events and workshops for the healthcare profession. The Group is well known for publishing the BMJ (British Medical Journal), over 25 specialist journals, BMJ Clinical Evidence and BMJ Best Treatments (currently available in the UK from AskBoots.com). BMJ Group is owned by the British Medical Association. It is editorially independent and the articles and content it publishes are not intended to reflect BMA policy.
ots Originaltext: univadis
Im Internet recherchierbar: http://www.presseportal.ch
Contact details: MSD RBSC GMBH, Andreas Marmsoler,
Richard-Reitzner-Allee 1, 85540 Haar, Germany, Tel:
+49-89-45-66-55-133, E-Mail: firstname.lastname@example.org; BMJ Group,
Rachel Davies, BMA House, Tavistock Square, London WC1H 9JR, UK, Tel:
+44-20-7383-6529, E-Mail: email@example.com